Role of 64Cu-ATSM PET/CT for the localization of hypoxic areas in uterine cervical cancer - 64Cu-ATSM-UTERO-01/2009
- Conditions
- Patients affected by uterine cervical cancer (sensitivity for localizing area of hypoxia within tumoral masses will be evaluated )MedDRA version: 9.1Level: LLTClassification code 10007493
- Registration Number
- EUCTR2009-011682-91-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- 30
1. adult women (age >18years) 2. patients diagnosed with uterine cervical cancer (stage II and III) and scheduled for radiation therapy as the only treatment. 3. no previous chemiotherapy treatment before enrollment 4. signed informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
1. patients diagnosed with uterine cervical cancer and scheduled for radiation therapy as the only treatment. 2. adult women (age >18years) 3. signed informed consent
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.